Work

Abstract 344: IBI3014, a TROP2xPD-L1 bi-specific ADC integrating ADC killing with checkpoint blockade within one molecule, exhibits promising efficacy and safety in preclinical models

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-344

Authors: Xiguang Zhang, Yanping Jin, Jinchang Lu, Ninghuan Li, Zhihai Wu, Min Wu, Yan Bian, Fenggen Fu, Weiwei Wu, Shuaixiang Zhou, Huizhong Xiong

Institution: Innovent Biologics (China)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689533

Cites:

Cited by: 2

Related to: 10